Skip to main content
SpringerLink
Log in

Response of Early Stage Cutaneous T-Cell Lymphoma to Ultraviolet B Phototherapy

  • Chapter
Book cover Basic Mechanisms of Physiologic and Aberrant Lymphoproliferation in the Skin

Part of the book series: NATO ASI Series ((NSSA,volume 265))

  • 79 Accesses

Abstract

Twenty-five (71%) of 35 patients with cutaneous T-cell lymphoma (CTCL) treated with ultraviolet B (UVB) phototherapy achieved a total remission. Median time to remission was 5 months, and median duration of the remission was 22 months. Twenty-five (83%) of patients with disease limited to patches (Stage I) achieved remission, whereas none of the patients with plaque level disease (Stage II) achieved remission. Of the 25 patients who achieved complete remission, five (20%) had a recurrence of CTCL. These results suggest that UVB phototherapy is an effective treatment for patients with early stage I disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abel EA, DG Deneau, EM Farber et al., 1981. PUVA treatment of erythrodermic and plaque type mycosis fungoides. J. Am. Acad. Dermatol., 4: 423–429.

    Article  PubMed  CAS  Google Scholar 

  • Aberer W, G Schuler, G Stingi et al., 1981. UV light depletes surface markers of Langer-hans cells. J. Invest. Dermatol., 76: 202–210.

    Article  PubMed  CAS  Google Scholar 

  • Ansel JC, TA Luger and I Green, 1983. The effect of in vitro and in vivo UV irradiation on the production of ETAF activity by human and murine keratinocytes. J. Invest. Dermatol., 81: 519–523.

    Article  PubMed  CAS  Google Scholar 

  • Austad J and LR Braathen, 1985. Effect of UVB on alloactivating and antigen-presenting capacity of human epidermal Langerhans cells. Scand. J. Immunol., 21: 417–423.

    Article  PubMed  CAS  Google Scholar 

  • Bunn PA, AB Fischmann, GP Schechter et al., 1979. Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomas. Cancer Treat. Rep., 63: 713–717.

    PubMed  Google Scholar 

  • Bunn PA Jr and SI Lamberg, 1979. Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat. Rep., 63: 725–728.

    PubMed  Google Scholar 

  • Bunn PA and DA Norris, 1990. The therapeutic role of interferons and monoclonal antibodies in cutaneous T-cell lymphomas. J. Invest. Dermatol., 95: 209S-212S.

    Article  Google Scholar 

  • Edelson R, C Berger, F Gasparro et al., 1987. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N. Engl. J. Med., 316: 297–303.

    Article  PubMed  CAS  Google Scholar 

  • Gilchrest BA, 1979. Methoxsalen photochemotherapy for mycosis fungoides. Cancer Treat. Rep., 63: 663–667.

    PubMed  CAS  Google Scholar 

  • Grozea PN, SE Jones, EM McKelvey et al., 1979. Combination chemotherapy for mycosis fungoides: A Southwest oncology group study. Cancer Treat. Rep., 63: 647–653.

    PubMed  CAS  Google Scholar 

  • Hamminga L, J Hermans, EM Noordijk et al., 1982. Cutaneous T-cell lymphoma: Clinoco-pathological relationships, therapy and survival in ninety-two patients. Br. J. Dermatol., 107: 145–156.

    Article  PubMed  CAS  Google Scholar 

  • Hamminga B, EM Noordijk and WA van Vloten, 1982b. Treatment of mycosis fungoides: Total skin electron beam irradiation vs. topical mechlorethamine therapy. Arch. Dermatol., 118: 150–153.

    Article  PubMed  CAS  Google Scholar 

  • Hoppe RT, EA Abel, DG Deneau et al., 1987. Mycosis fiingoides: Management with topical nitrogen mustard. J. Clin. Oncol., 5: 1796–1803.

    PubMed  CAS  Google Scholar 

  • Hoppe RT, RS Cox, Z Fuks et al., 1979. Electron-beam therapy for mycosis fungoides: The Stanford University experience. Cancer Treat. Rep., 63: 691–700.

    PubMed  CAS  Google Scholar 

  • Hostetler LW, HN Ananthaswamy and ML Kripke, 1986. Generation of tumor-specific transplantation antigens by UV radiation can occur independently of neoplastic transforma tion. J. Immunol., 137: 2721–2725.

    PubMed  CAS  Google Scholar 

  • Kaplan EH, ST Rosen, DB Norris et al., 1990. Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma. J. Natl. Cancer Inst., 82: 208–212

    Article  PubMed  CAS  Google Scholar 

  • Knox SJ, R Levy, S Hodgkinson et al., 1991. Observations on the effect of chimeric anti-CD4 monoclonal antibody in patients with mycosis fiingoides. Blood, 77: 20–30.

    PubMed  CAS  Google Scholar 

  • Kaye FJ, PA Bunn, Jr, SM Steinberg et al., 1989. A randomized trial comparing combina tion electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N. Engl. J. Med., 321: 1784–1790.

    Article  PubMed  CAS  Google Scholar 

  • Kupper TS, AO Chua, P Flood et al., 1987. Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation. J. Clin. Invest., 80: 430–436

    Article  PubMed  CAS  Google Scholar 

  • Kuzel TM, R Gilyon R, E Springer et al., 1990. Interferon alfa-2a combined with photo therapy in the treatment of cutaneous T-cell lymphoma. J. Natl. Cancer Inst., 82: 203–207.

    Article  PubMed  CAS  Google Scholar 

  • Le Bourgeois JP, E Haddad, G Mannello et al., 1987. The indications for total cutaneous electron beam radiation therapy of mycosis fungoides. Int. J. Radiat. Oncol. Biol. Phys., 13: 189–193.

    Article  PubMed  Google Scholar 

  • Lowe NJ, DJ Cripps, PA Dutton PA et al., 1979. Photochemotherapy for mycosis fungoi des: A clinical and histologic study. Dermatol., 115: 50–53.

    CAS  Google Scholar 

  • Maddox AM, BD Kahan, S Tuker, et al., 1985. Remission in skin infiltrate of a patient with mycosis fungoides treated with cyclosporin. J. Am. Acad. Dermatol., 12: 952–956.

    Article  PubMed  CAS  Google Scholar 

  • McDonald CJ and JR Bertino, 1978. Treatment of mycosis fungoides lymphoma: Effectiveness of infusions of methotrexate followed by oral citrovorum factor. Cancer Treat. Rep., 62: 1009–1014.

    PubMed  CAS  Google Scholar 

  • Merlo CJ, RT Hoppe, E Abel et al., 1987. Extracutaneous mycosis fungoides. Cancer, 60: 397–402.

    Article  PubMed  CAS  Google Scholar 

  • Milstein HJ, EC Vonderheid, EJ Van Scott et al., 1982. Home ultraviolet phototherapy of early mycosis fungoides: Preliminary observations. J. Amer. Acad. Dermatol., 6: 355–362.

    Article  CAS  Google Scholar 

  • Molin L, K Thomsen, G Volden et al., 1987. Retinoids and systemic chemotherapy in cases of advanced mycosis fungoides. A report from the Scandinavian Mycosis Fungoides Group. Acta Derm. Venereol. (Stockh), 67: 179–182.

    CAS  Google Scholar 

  • Moreland AA, DB Robertson and LT Heffner, 1985. Treatment of cutaneous T cell lymphoma with cyclosporin A. J. Am. Acad. Dermatol., 12: 886–887.

    Article  PubMed  CAS  Google Scholar 

  • Nisce LZ and B Safai, 1979. Once weekly total skin electron beam therapy for mycosis fungoides. Cancer Treat. Rep., 63: 633–638.

    PubMed  CAS  Google Scholar 

  • Norris DA, MB Lyons, MH Middleton et al., 1990. Ultraviolet radiation can either suppress or induce expression of intercellular adhesion molecule 1 (ICAM-1) on the surface of cultured human keratinocytes. J. Invest. Dermatol., 95: 132–138.

    Article  PubMed  CAS  Google Scholar 

  • Olsen EA, ST Rosen, RT Vollmer et al., 1989. Interferon alfa-2a in the treatment of cutaneous T cell lymphoma. J. Am. Acad. Dermatol., 20: 395–407.

    Article  PubMed  CAS  Google Scholar 

  • Oxholm A, P Oxholm, B Staberg et al., 1988. Immunohistological detection of interleukin I-like molecules and tumour necrosis factor in human epidermis before and after UVB-irra-diation in vivo. Br. J. Dermatol., 118: 369–376.

    Article  PubMed  CAS  Google Scholar 

  • Price NM, RT Hoppe and DG Deneau DG, 1983. Ointment-based mechlorethamine treatment for mycosis fungoides. Cancer, 52: 2214–2219.

    Article  PubMed  CAS  Google Scholar 

  • Powell FC, GT Siegel and SA Muller, 1984. Treatment of parapsoriasis and mycosis fungoides: The role of psoralen and long-wave ultraviolet A (PUVA). Mayo Clin. Proc., 59: 538–546.

    Article  PubMed  CAS  Google Scholar 

  • Ramsay DL, PS Halperin and A Zeleniuch Jacquotte, 1988. Topical mechlorethamine therapy for early stage mycosis fungoides. J. Am. Acad. Dermatol., 19: 684–691.

    Article  PubMed  CAS  Google Scholar 

  • Rasanen L, T Reunala, M Lehto et al., 1989. Immediate decrease in antigen-presenting function and delayed enhancement of interleukin-I production in human epidermal cells after in vivo UVB irradiation. Br. J. Dermatol., 120: 589–596.

    Article  PubMed  CAS  Google Scholar 

  • Roenigk HH, TM Kuzel, AP Skoutelis et al., 1990. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma. J. Invest. Dermatol., 95: 198S-205S.

    Article  Google Scholar 

  • Rosenbaum MM, HH Roenigk, WA Caro et al., 1985. Photochemotherapy in cutaneous T cell lymphoma and parapsoriasis en plaques. J. Am. Acad. Dermatol., 13: 613–622.

    Article  PubMed  CAS  Google Scholar 

  • Rowden G, TM Phillips, MG Lewis et al., 1979. Target role of Langerhans cells in mycosis fungoides: Transmission and immuno-electron microscope studies. J. Cut. Pathol., 6: 364–382.

    Article  CAS  Google Scholar 

  • Sanchez JL and AB Ackerman, 1979. The patch stage of mycosis fungoides: Criteria for histologic diagnosis. Am. J. Dermatopathol., 1: 5–26.

    PubMed  CAS  Google Scholar 

  • Sauder DN, FP Noonan, EC De Fabo et al., 1983. Ultraviolet radiation inhibits alloantigen presentation by epidermal cells: Partial reversal by the soluble epidermal cell product, epidermal cell-derived thymocyte-activating factor (ETAF). J. Invest. Dermatol., 80: 485–489.

    Article  PubMed  CAS  Google Scholar 

  • Slevin NJ, V Blair and ID Todd, 1987. Mycosis fungoides — Response to therapy and survival patterns in 85 cases. Br. J. Dermatol., 116: 47–53.

    Article  PubMed  CAS  Google Scholar 

  • Stingi G, LA Gazze-Stingl, W Aberer et al., 1981. Antigen presentation by murine epidermal Langerhans cell and its alteration by ultraviolet B light. J. Immunol., 127: 1707–1713.

    Google Scholar 

  • Tadros AAM, BS Tepperman, WM Hryniuk et al., 1983. Total skin electron irradiation of mycosis fungoides: Failure analysis and prognostic factors. Int. J. Radiat. Oncol. Biol. Phys., 9: 1279–

    Article  PubMed  CAS  Google Scholar 

  • Tirelli U, A Carbone, A Veronesi et al., 1982. Combination chemotherapy with cyclophos phamide, vincristine, and prednisone (CVP) in TNM — classified stage IV mycosis fungoides. Cancer Treat. Rep., 66: 167–169

    PubMed  CAS  Google Scholar 

  • Tron VA, D Rosenthal and DN Sauder, 1988. Epidermal interleukin-1 is increased in cutaneous T-cell lymphoma. J. Invest. Dermatol., 90: 378–381.

    Article  PubMed  CAS  Google Scholar 

  • Urbanski A, T Schwarz, P Neuner et al., 1990. Ultraviolet light induces increased circula ting interleukin-6 in humans. J. Invest. Dermatol., 94: 808–811.

    Article  PubMed  CAS  Google Scholar 

  • Van Vloten WA, H De Vroome and EM Noordijk, 1985. Total skin electron beam irradiation for cutaneous T-cell lymphoma (mycosis fungoides). Br. J. Dermatol., 112: 697–702.

    Article  PubMed  Google Scholar 

  • Vegna ML, G Papa, D Defazio et al., 1990. Interferon alpha-2a in cutaneous T-cell lymphoma. Eur. J. Haematol., 45: Suppl. 52: 32–35

    Google Scholar 

  • Volden G and TE Larsen, 1978. Remissions of mycosis fungoides induced by nitrogen mustard (HN2). Dermatologica, 156: 129–141.

    Article  PubMed  CAS  Google Scholar 

  • Vonderheid EC, ET Tan, AF Kantor et al., 1989. Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma. J. Am. Acad. Dermatol., 20: 416–428.

    Article  PubMed  CAS  Google Scholar 

  • Vonderheid EC, EJ Van Scott, PE Wallner et al., 1979. A 10 year experience with topical mechlorethamine for mycosis fungoides: Comparison with patients treated by total-skin electron beam radiation therapy. Cancer Treat. Rep., 63: 681–689.

    PubMed  CAS  Google Scholar 

  • Zachariae H, E Grunnet, K Thestrup-Pedersen et al., 1982. Oral retinoid in combination with bleomycin, cyclophosphamide, prednisone, and transfer factor in mycosis fungoides. Acta Derm. Venereol., 62: 162–164.

    PubMed  CAS  Google Scholar 

  • Zachariae H, K Thestrup-Pedersen and H Sogaard, 1985. Topical nitrogen mustard in early mycosis fungoides. Acta Dermatol. Venereol. (Stockh)., 65: 53–58

    CAS  Google Scholar 

  • Zakem MH, BR David, DJ Adelstein et al., 1986. Treatment of advanced stage mycosis fungoides with bleomycin, doxorubicin and methotrexate with topical nitrogen mustard (BAM-M). Cancer, 58: 2611–2616.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Perelman Department of Dermatology and Photomedicine Section, New York University School of Medicine, New York, New York, USA

    David L. Ramsay, Karen M. Lish, Cynthia B. Yalowitz & Nicholas A. Soter

Authors
  1. David L. Ramsay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karen M. Lish
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cynthia B. Yalowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nicholas A. Soter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. UMD-New Jersey Medical School, Newark, New Jersey, USA

    W. Clark Lambert

  2. University of Florence, Florence, Italy

    Benvenuto Giannotti

  3. University Hospital, Utrecht, Utrecht, The Netherlands

    Willem A. van Vloten

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ramsay, D.L., Lish, K.M., Yalowitz, C.B., Soter, N.A. (1994). Response of Early Stage Cutaneous T-Cell Lymphoma to Ultraviolet B Phototherapy. In: Lambert, W.C., Giannotti, B., van Vloten, W.A. (eds) Basic Mechanisms of Physiologic and Aberrant Lymphoproliferation in the Skin. NATO ASI Series, vol 265. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1861-7_39

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1861-7_39

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5756-8

  • Online ISBN: 978-1-4615-1861-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation